Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Condition(s):Chronic Anemia; Transfusional HemosiderosisLast Updated:June 29, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Anemia; Transfusional HemosiderosisLast Updated:June 29, 2021Completed
Condition(s):Beta-thalassemia Major; Hemosiderosis; Iron Overload; Rare AnemiaLast Updated:August 31, 2011Completed
Condition(s):Myelodysplastic Syndromes; Transfusion Dependent Iron OverloadLast Updated:May 31, 2017Completed
Condition(s):Porphyria Cutanea TardaLast Updated:February 10, 2014Completed
Condition(s):Transfusional Iron Overload; β-thalassemia Major; Pediatric Rare AnemiaLast Updated:March 20, 2017Completed
Condition(s):Non-alcoholic Steatohepatitis; Increased Iron Storage / Disturbed DistributionLast Updated:July 20, 2012Completed
Condition(s):Myelodysplastic Syndromes; HemosiderosisLast Updated:November 22, 2016Completed
Condition(s):Thalassemia (Transfusion Delendent)Last Updated:April 20, 2017Withdrawn
Condition(s):Transfusional Iron Overload in β-thalassemiaLast Updated:May 30, 2011Completed
Condition(s):Iron OverloadLast Updated:November 17, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.